Delivery Order SPE2DR25D2204-SPE2DR26FS20D
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for $18,343.17 on November 4, 2025, for the supply of Biktarvy 50-200-25 mg tablets in packages of 30 units. The contract represents a firm fixed-price delivery order with an ultimate completion date of November 5, 2025, and was competitively awarded without set-aside provisions. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 31, 2025, for the supply of Biktarvy 50-200-25 mg tablets (30-count units) with a ceiling value of $10,334.55. This firm fixed price, non-set-aside contract is scheduled for ultimate completion by November 3, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a routine pharmaceutical procurement supporting federal...
- The Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp on November 4, 2025, for the supply of Biktarvy 50-200-25 mg tablets in quantities of 30 units. This competitively awarded, firm fixed-price delivery order is valued at $42,130.29 and is scheduled for completion by November 5, 2025. The contract carries no set-aside designation, reflecting open competition among qualified vendors. AmerisourceBergen Drug Corp, a major pharmaceutical distributor...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for $13,986.71 on November 5, 2025, for the supply of Biktarvy 50-200-25 mg tablets in quantities of 30. The contract employs firm fixed pricing with no set-aside designation and is scheduled for completion by November 6, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor and will perform the work at its corporate office location in...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Biktarvy 50-200-25 mg tablets in quantities of 30 units. This is a firm fixed-price delivery order valued at $18,577.92, with an ultimate completion date of August 15, 2025. The contract is non-set-aside and represents a competitive award under the federal procurement process. The place of performance is AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $47,060.31 to AmerisourceBergen Drug Corp for the supply of Biktarvy 50-200-25 mg tablets in quantities of 30 units. This is a firm fixed-price, competitively awarded contract with no set-aside designation, scheduled for completion by November 17, 2025. The delivery order was issued on November 14, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 28, 2025, for the supply of Biktarvy 50-200-25 mg tablets in quantities of 30 units. This is a firm fixed-price delivery order with a ceiling value of $16,491.43 and an ultimate completion date of September 29, 2025. The contract carries no set-aside designation, indicating it was competitively awarded. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $53,908.10 to AmerisourceBergen Drug Corp for Biktarvy 50-200-25 mg tablets (30-count units) on August 6, 2025, with an ultimate completion date of August 7, 2025. This firm fixed-price delivery order represents a non-set-aside, competitively awarded contract for pharmaceutical supply to support federal medical procurement needs. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of Biktarvy 50-200-25 mg tablets in quantities of 30 units. This competitive award, valued at $11,159.05 under a firm fixed-price contract type, is scheduled for completion by August 25, 2025. The contract will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. No set-aside designation was applied to this award, indicating it was...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $2,734.88 on June 2, 2025, for the supply of Biktarvy 50-200-25 mg tablets in a quantity of 30 units. This is a firm fixed price delivery order with an ultimate completion date of June 3, 2025, and represents a non-competitive set-aside award. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- SPE2DR25D2204Indefinite Delivery Contract
- SPE2DR25D2204-SPE2DR26FS20DDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $35,151.10 to AmerisourceBergen Drug Corp on November 14, 2025, for the supply of Biktarvy 50-200-25 mg tablets in quantities of 30 units. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under open competition. The contract is scheduled for completion by November 17, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and running through December 2026. As a prime vendor to the Defense Logistics Agency, AmerisourceBergen Drug Corp supplies critical pharmaceutical products and medical commodities to support military healthcare programs worldwide, including medications, vaccines, and specialized medical supplies across multiple therapeutic domains for the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $35.2k | 11/14/25 |